Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)

BACKGROUND: In order to improve therapy for HNSCC patients, novel methods to predict and combat local and/or distant tumour relapses are urgently needed. This study has been dedicated to the hypothesis that Rac1, a Rho GTPase, is implicated in HNSCC insensitivity to chemo-radiotherapy resulting in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Skvortsov, S, Dudás, J, Eichberger, P, Witsch-Baumgartner, M, Loeffler-Ragg, J, Pritz, C, Schartinger, V H, Maier, H, Hall, J, Debbage, P, Riechelmann, H, Lukas, P, Skvortsova, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037830/
https://www.ncbi.nlm.nih.gov/pubmed/24786604
http://dx.doi.org/10.1038/bjc.2014.221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037830/
https://www.ncbi.nlm.nih.gov/pubmed/24786604
http://dx.doi.org/10.1038/bjc.2014.221

Ejemplares similares